Key Covid-19 bulk drugs see 180% price increase over four months

However, there is no shortage expected at the retail level anytime soon

Prices of key bulk drugs that go into making medicines actively used to treat Covid patients and relatives have surged in the range of 25-180 per cent in the past few months owing to two factors — a sudden surge in demand and slower supplies from China.
 
No shortage, however, is expected at the retail level anytime soon as big firms carry a few months of inventory.
 
Prices of the active pharmaceutical ingredient (API) of paracetamol, azithromycin, doxycycline, ivermectin etc have gone up. These are either antibiotics or analgesics and other drugs used to treat Covid-19.
 
Sample